Post‐conference review of oral session 6 and short talk in the 17th international IgA nephropathy conference, Tokyo 2023

Oral session 6 titled ‘Clinical Trial 1’ and the short talk on ‘Landscape of Clinical Trials in IgAN‐What's beyond the Horizon?’ took place on 30 September 2023 in the symposium venue. The short talk highlighted the increase in IgAN trials in the last decade and the challenges of global clinical trials from the site investigator perspective. The talk also underlined the importance of relooking and repurposing already available and approved therapeutics. There were six oral sessions that focussed mainly on the interim results of ongoing clinical trials as well as early phase results with new investigational agents.